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Protein O-phosphorylation often occurs reciprocally with
O-GlcNAc modification and represents a regulatory principle
for proteins. O-phosphorylation of serine by glycogen
synthase kinase-3b on Snail1, a transcriptional repressor of
E-cadherin and a key regulator of the epithelial–mesenchy-
mal transition (EMT) programme, results in its proteasomal
degradation. We show that by suppressing O-phosphoryla-
tion-mediated degradation, O-GlcNAc at serine112 stabilizes
Snail1 and thus increases its repressor function, which in turn
attenuates E-cadherin mRNA expression. Hyperglycaemic
condition enhances O-GlcNAc modification and initiates
EMT by transcriptional suppression of E-cadherin through
Snail1. Thus, dynamic reciprocal O-phosphorylation and O-
GlcNAc modification of Snail1 constitute a molecular link
between cellular glucose metabolism and the control of EMT.
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Introduction
Metabolic regulation is important for the proliferation and
survival of cancer cells, as indicated by their high rate of
aerobic glycolysis (Warburg, 1956; Hsu and Sabatini, 2008;
Vander Heiden et al, 2009). Glucose, as a major carbon and
energy source, provides ATP and various macromolecules
required for cancer cell growth. Through ATP citrate lyase,
glucose metabolism of cancer cells is tightly linked to lipid
synthesis (Hatzivassiliou et al, 2005) and histone acetylation
(Wellen et al, 2009). Therefore, glucose utilization by ATP
citrate lyase not only sustains proliferation of cancer cells but
also affects gene expression. Indeed, glucose-dependent reg-
ulation of histone acetylation has been shown to selectively
affect the expression of genes required for aerobic glycolysis
(Wellen et al, 2009).
In addition to being a source of ATP and various cellular
macromolecules, 2–5% of glucose enters the hexosamine
biosynthetic pathway for the synthesis of uridine 50-dipho-
spho-N-acetylglucosamine (UDP-GlcNAc) (McClain and
Crook, 1996), which is transferred by O-GlcNAc trans-
ferase (OGT) to serine (Ser) or threonine (Thr) residues of
many proteins to yield the O-linked b-N-acetylglucosamine
(O-GlcNAc) modification (Wells et al, 2001). This modifica-
tion is highly dynamic and occurs reciprocal to O-phospho-
rylation in various nuclear and cytoplasmic proteins (Love
and Hanover, 2005; Hart et al, 2007). The reciprocity of
O-GlcNAc modification and O-phosphorylation is important
in regulating the function of many proteins within signalling
cascades and in degrading certain proteins such as b-catenin
(Kamemura and Hart, 2003). Serial O-phosphorylation of Ser
and Thr is mediated by glycogen synthase kinase-3b (GSK-
3b), a pivotal kinase involved in glycogen metabolism and
Wnt signalling (Yook et al, 2006). Inhibition of GSK-3b, on
the other hand, results in perturbation of O-GlcNAc modifica-
tion on many transcription factors and structural proteins,
indicating diverse roles for the modification in cellular signal-
ling (Wang et al, 2007). As a case in point, oncogenes and
tumour suppressor proteins as well as ligand-responsive
transcription factors are modified by O-GlcNAc, whose
dynamic exchange with O-phosphorylation is involved in
the regulation of their activity (Cheng et al, 2000;
Kamemura and Hart, 2003; Love and Hanover, 2005; Hart
et al, 2007).
Regulation of cell–cell adhesion is essential for embryonic
development and cell differentiation as well as for homeo-
stasis of the epithelium. Loss of cell adhesion occurs in many
types of cancer and correlates with tumour progression,
metastatic potential, and poor prognosis (Peinado et al,
2007). E-cadherin, the prototypic member of the cadherin
family, is a major component of adherent junctions and
regulates cell adhesion via homophilic interactions between
its extracellular domains on opposing plasma membranes and
by binding of its cytosolic domain to the cytoskeleton via
b-catenin (Gottardi and Gumbiner, 2004). Down-regulation
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of E-cadherin is a critical step in the epithelial–mesench-
ymal transition (EMT) and thus carcinoma invasion and
progression.
Snail1, a transcriptional repressor of E-cadherin, is a key
regulator of EMT (Nieto, 2002; Barrallo-Gimeno and Nieto,
2005). Of note, Snail1 is serially O-phosphorylated by CK1
and GSK-3b prior to b-TrCP-mediated ubiquitination and
proteasomal degradation (Zhou et al, 2004; Xu et al, 2010).
Conversely, inhibition of GSK-3b by Wnt signalling leads to
Snail1 stabilization, resulting in down-regulation of E-cadher-
in and stimulation of EMT programmes (Yook et al, 2005,
2006). As O-phosphorylation often occurs reciprocally with
O-GlcNAc modification, we sought to determine the extent of
O-GlcNAc modification of Snail1 and its potential function
in regulation of EMT. Here, we show that the O-GlcNAc
modification at Ser112 stabilizes Snail1 by suppressing its
O-phosphorylation-mediated degradation. Under hypergly-
caemic conditions and with enhanced protein O-GlcNAc
modification, Snail1 stimulates EMT through transcriptional
suppression of E-cadherin. These data provide mechanistic
insight into Snail1 function, showing a molecular link
between the glucose metabolism of cells and the control of
EMT by reciprocal O-phosphorylation and O-GlcNAc modifi-
cation of Snail1.
Results
The E-cadherin suppressor Snail1 is modified
by O-GlcNAc at Ser112
O-GlcNAc modifies various transcription factors and cellular
proteins in a process dynamically reciprocal to O-phosphor-
ylation of the same Ser and Thr residues or adjacent residues,
and is important in regulating function of the relevant protein
(Love and Hanover, 2005; Hart et al, 2007). As the E-cadherin
repressor Snail1 is regulated by O-phosphorylation through
GSK-3b (Yook et al, 2006) as a key step in its b-TrCP-mediated
ubiquitination followed by proteasomal degradation (Zhou
et al, 2004; Yook et al, 2006), we sought to determine whether
Snail1 is modified with O-GlcNAc. For this purpose, human
embryonic kidney (HEK) cells 293 were transfected to express
FLAG-tagged Snail1 and immunoprecipitated Snail1 was
probed with the O-GlcNAc-specific monoclonal antibody
CTD110.6. We were able to unequivocally detect O-GlcNAc
on Snail1 in an amount, which could be significantly in-
creased by co-expressed OGT (Figure 1A).
To determine the existence and location of the O-GlcNAc
site(s) on Snail1 by mass spectrometry analysis, Snail1 was
immunoprecipitated from HEK293 cells co-expressing OGT
and subjected to SDS–PAGE (Figure 1B). The Snail1 band was
then in-gel digested with both trypsin and chymotrypsin, and
analysed by quadrupole time-of-flight tandem mass spectro-
metry (Q-ToF MS). Both unmodified and O-GlcNAc-modified
99–113 peptides of Snail1 (GSQPPSPPSPAPSSF) were ob-
served at [Mþ 2H]2þ m/z 720.4 and m/z 821.9, respectively
(Figure 1C and D). The molecular mass of the O-GlcNAc-
bearing peptide was 203.08 Da higher than that of the
unmodified peptide and its spectrum showed the GlcNAc
oxonium ion and several GlcNAc fragment ions. These in-
dicate that the 99–113 peptide of Snail1 carries O-GlcNAc,
although the exact position of the O-GlcNAc site on this
peptide could not be defined because of fragmentation of
O-GlcNAc from the peptide during Q-ToF MS analysis. To
determine the specific O-GlcNAc sites, we created deletions
and site-specific point mutants of Snail1 (Figure 2A). When
amino acids 110–120 were deleted, much less O-GlcNAc could
be detected by immunoblot using the monoclonal antibody
CTD110.6 compared with wild type, whereas deleting
amino acids 87–109 had no effect on O-GlcNAc detection
(Figure 2B), suggesting that the site of O-GlcNAc modification
was either Ser111 or Ser112. Indeed, exchange of Ser112 with
Ala largely resulted in loss of O-GlcNAc, indicating that this is
the major, if not the only Snail1 site carrying the O-GlcNAc
modification (Figure 2C).
O-GlcNAc modification at Ser112 prevents Snail1
degradation
Next, to examine whether endogenous Snail1 is modified by
O-GlcNAc, we used succinylated wheat germ agglutinin
(sWGA) for affinity purification of A549 total cell lysates
(Love and Hanover, 2005; Gambetta et al, 2009) and pro-
bed the precipitates with an antibody against Snail1. We
successfully detected O-GlcNAc-modified endogenous Snail1
(Figure 3A). The specificity of the lectin-affinity purification
was shown by addition of the inhibitory monosaccharide
GlcNAc (Figure 3A). We then investigated whether the
O-GlcNAc modification on Snail1 is of functional significance
for its turnover. As serial O-phosphorylation by GSK-3b
(Zhou et al, 2004; Yook et al, 2005) initiates the proteasomal
degradation of Snail1 (Yook et al, 2005, 2006), we reasoned
that the O-GlcNAc modification of the adjacent Ser112 could
affect Snail1 stability. To verify this, we used inhibitors of
O-GlcNAcase (OGA), PUGNAc, or NAG-thiazoline (NTZ),
which cause a shift in equilibrium from O-phosphorylation
to O-GlcNAc modification. Following the treatment of A549
carcinoma cells with either OGA inhibitor, an increased
steady state amount of Snail1 as well as enhanced
O-GlcNAc modification of various cellular proteins was
observed (Figure 3B), although without changes in Snail1
mRNA level (Supplementary Figure 1A).
Furthermore, overexpression of OGT in HEK293 cells
drastically decreased the level of O-phosphorylation on
Ser of Snail1, accompanied by an increase in Snail1 protein
expression (Figure 3C). We also observed that OGT over-
expression decreased the interaction between Snail1 and
GSK-3b (Figure 3D), indicating that O-GlcNAc modification
of Snail1 affects GSK-3b-mediated protein stabilization.
Indeed, treatment with OGA inhibitors consistently increased
Snail1 half-life (Figure 3E), and this was paralleled by sup-
pression of Snail1 ubiquitination (Figure 3F) in a manner
similar to that described for p53 (Yang et al, 2006).
As expected, no effect was observed on the half-life and
expression levels of the S112A Snail1 mutant (Figure 3G
and H). Additional experiments in which either OGT
(Supplementary Figure 2A) or OGA (Supplementary Figure
2B) were overexpressed corroborated the stabilizing effect of
increased O-GlcNAc modification on Snail1.
Snail1 levels are influenced by cellular glucose
concentration
As the extent of protein O-GlcNAc modification is directly
related to the glucose influx through the hexosamine biosyn-
thetic pathway (Kang et al, 2009), we next studied the effect
of glucose concentration in the culture medium on Snail1
levels. An increase in endogenous Snail1 protein was clearly
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observed under hyperglycaemic culture conditions (25 mM
glucose) as compared with normoglycaemic conditions
(5 mM glucose) (Figure 4A). This was apparently not due to
increased de novo synthesis of Snail1 as the hyperglycaemic
condition had no effect on its mRNA level (Supplementary
Figure 1B). Rather, this effect was related to the O-GlcNAc
modification as siRNA-mediated knock-down of OGT strongly
reduced the effect of hyperglycaemic culture conditions on
Snail1 expression (Figure 4B). Furthermore, hyperglycaemia
in combination with OGT overexpression increased the
amount of Snail1, but not that of mutant S112A Snail1
(Figure 4C and D). Together, these results suggest that
enhanced glucose influx directly affects O-GlcNAc modifica-
tion on Snail1, which in turn results in increased Snail1
protein level. Next, we investigated the generality of
the glucose concentration on the O-GlcNAc modification
of Snail1. By analysing MCF-7, HeLa, and SW480 cells, we
found that their amount of Snail1 increased under hypergly-
caemic culture conditions (25 mM glucose) as compared with
normoglycaemic conditions (5 mM glucose) (Figure 4E). To
demonstrate the O-GlcNAc modification on Snail1 in these
cell lines, sWGA-affinity purification of total cell lysates was
performed and Snail1 demonstrated by immunoblot analysis
of the precipitate (Figure 4F). Specificity was shown by
addition of the inhibitory monosaccharide GlcNAc during
sWGA-affinity purification (Figure 4F). These results show
that O-GlcNAc modification on Snail1 commonly occurs in
various cancer cell lines.
Figure 1 The E-cadherin repressor Snail1 carries the O-GlcNAc modification. (A) Western blot analysis for O-GlcNAc of immunoprecipitated
Snail1 from OGT-expressing or control vector-transfected HEK 293 cells. a-tubulin was included as a loading control. (B) FLAG-tagged Snail1
was immunoprecipitated from OGT-overexpressing HEK 293 cells, separated by SDS–PAGE, and visualized by Coomassie G250 (arrow).
This band was in-gel digested and analysed by mass spectrometry. (C) MS/MS spectrum and sequencing result of an unmodified peptide from
in-gel digestion at [Mþ 2H]2þ m/z 720.4. The peptide was identified as GSQPPSPPSPAPSSF, corresponding to the 99–113 fragment of Snail1.
(D) MS/MS spectrum and sequencing result of an O-GlcNAc-bearing 99–113 peptide at [Mþ 2H]2þ m/z 821.9. Difference in molecular mass
between the unmodified peptide (C) and the O-GlcNAc-bearing peptide (D) is B203 Da.
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O-GlcNAc modification on Snail1 down-regulates
E-cadherin and promotes EMT
Snail1 has been proposed to have important functions in
embryonic development and cancer progression through its
function as an E-cadherin repressor and its role in EMT
(Nieto, 2002; Peinado et al, 2007). To determine the func-
tional significance of O-GlcNAc-mediated stabilization of
Snail1 on E-cadherin expression, we performed the luciferase
gene reporter assay for the E-cadherin proximal promoter and
investigated endogenous E-cadherin mRNA levels. As it is
known that Snail1, upon binding to the three E-boxes of the
human E-cadherin promoter, blocks transcription of E-cad-
herin (Batlle et al, 2000), we used a triple E-box mutant
(3xMut) as the negative control of the gene reporter assay.
The A549 cells were treated with OGA inhibitors to
maximize the amount of O-GlcNAc-modified protein. Both
OGA inhibitors used in our experiments resulted in suppres-
sion of E-cadherin promoter activity and E-cadherin mRNA
transcription, while no effect was observed when the
triple E-box mutant was analysed (Figure 5A). Conversely,
following siRNA-mediated knock-down of endogenous OGT
(see Figure 4B) to prevent the O-GlcNAc modification,
E-cadherin promoter activity and E-cadherin mRNA tran-
scription increased compared with the triple E-box mutant
(Figure 5B). In agreement with our observation that hyper-
glycaemic conditions increase O-GlcNAc modification on
Snail1 (see Figure 4A–C), hyperglycaemic conditions resulted
in suppression of E-cadherin promoter activity and E-cadher-
in mRNA transcription (Figure 5C). Together, these data
strongly suggest that glucose is involved in the control of
E-cadherin transcription through increased O-GlcNAc mod-
ification on Snail1.
OGT is ubiquitous in cells and tissues (Hanover et al, 1999;
Hart et al, 2007). The fact that Snail1 expression is important
for the invasion and metastasis formation in human cancers
raises the possibility that OGT activation and subsequent
Snail1 stabilization may have a function in the recurrence
and metastatic progression of cancer. Therefore, we exam-
ined OGT and Snail1 expression in human pancreatic cancer
tissues. In all examined cases, OGT and Snail1 protein
were consistently co-expressed in the invasive cancer cells
(Supplementary Figure 3), suggesting that O-GlcNAc-
mediated stabilization of Snail1 is relevant in the condition
of human cancer.
Given that increased O-GlcNAc modification of Snail1
results in its accumulation, which in turn suppresses
E-cadherin proximal promoter activity, we sought to deter-
mine the effect of O-GlcNAc modification on Snail1 in terms
of cancer cell migration and invasive progression using non-
invasive MCF-7 cells. As shown in Figure 6, OGT-overexpres-
sing MCF-7 cells exhibited robust cellular migration and
invasion as compared with non-transfected MCF-7 cells.
Importantly, these migratory and invasive properties were
largely rescued by shRNA-mediated knock-down of Snail1,
and the invasive properties because of OGT-mediated Snail1
expression were confirmed by immunohistochemical detec-
tion of OGT and Snail1 in the chorioallantoic membrane
(CAM) samples (Supplementary Figure 4). Inversely, siRNA-
mediated OGT knock-down inhibited cell migration com-
pared with control. Moreover, knock-down of OGT abolished
cell migration by overexpression of wild-type Snail1, while
cell migration by overexpression of S112A mutant Snail1 was
not abolished (Supplementary Figure 5). These data suggest
that Snail1 is one of the important regulators responsible
for OGT-mediated cellular migration and the invasive pro-
gramme (Figure 6).
Discussion
Snail1 has a regulatory function in the EMT programme, a
key feature of tumour development and progression, and is
important for organ development in the embryo. This study
revealed the presence of O-GlcNAc, an important regulatory
posttranslational protein modification, on Ser112 of Snail1.
Glucose level regulated O-GlcNAc on Snail1, resulting in an
increase of O-GlcNAc modification with hyperglycaemia.
Importantly, the O-GlcNAc modification stabilized Snail1,
whose increased amounts caused down-regulation of E-cad-
herin through transcriptional repression and resulted in EMT.
Human and other mammalian Snail1 proteins have
a highly conserved b-catenin-like consensus motif. This
region of Snail1 is O-phosphorylated by GSK-3b, followed
by b-TrCP-dependent ubiquitination and rapid proteasomal
degradation, indicating that O-phosphorylation by GSK-3b is
Figure 2 Ser112 of Snail1 carries O-GlcNAc. (A) Deletion mutants
of Snail1 analysed for the presence of O-GlcNAc. (B) FLAG-tagged
wt Snail1, D87–109 Snail1, and D110–120 Snail1 were co-
expressed with OGT in HEK293 cells. Wt and deletion mutants of
Snail1 were immunoprecipitated with anti-FLAG beads, and immu-
noblotted for O-GlcNAc. (C) FLAG-tagged wt or point-mutated
Snail1 were co-expressed with OGT in HEK293 cells. Wt and
point mutants of Snail1 were immunoprecipitated with anti-FLAG
beads, and immunoblotted for O-GlcNAc.
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Figure 3 Presence of O-GlcNAc stabilizes Snail1 expression by inhibiting O-phosphorylation. (A) A549 cells were grown under hypergly-
caemic condition (25 mM) and cell lysates were subjected to sWGA-lectin-affinity purification and the precipitates analysed with western blot
for endogenous Snail1. For control, monosaccharide inhibitor GlcNAc (20 mM) was added during sWGA-lectin-affinity purification.
Experiments were performed in duplicate (1 and 2). (B) Western blot analysis for Snail1 and O-GlcNAc from A549 cells in the presence/
absence of OGA inhibitors PUGNAc or NAG-Thiazoline. a-tubulin was included as a loading control. (C) FLAG/HIS-tagged Snail1 was
immunoprecipitated with Ni-Ti agarose from HEK293 cells and the precipitate analysed by western blot with anti-phospho-serine antibody and
anti-FLAG antibody. Overexpression of OGT drastically reduces phospho-serine on Snail1. (D) FLAG-Snail1, HA-GSK-3b, and OGT were
overexpressed in A549 cells as indicated. FLAG-Snail1 was immunoprecipitated and the precipitate immunoblotted with anti-HA antibody and
anti-FLAG antibody, respectively. Arrow indicates HA-GSK-3b. (E) Half-life of Snail1 is increased by OGA inhibitors PUGNAc or NAG-
Thiazoline. Cells were treated with cycloheximide for the indicated time and Snail1 level was analysed by western blotting and densitometry
(n¼ 3; data are represented as mean±s.d., *Po0.01, **Po0.02 by Student’s t-test). (F) Western blot analysis for ubiquitin on Snail1
immunoprecipitated from HEK293 cells in the presence/absence of OGA inhibitor PUGNAc. The cells were treated with MG132 for proteasome
inhibition. (G) Half-life of S112A mutant Snail1 in the presence/absence of OGA inhibitor PUGNAc. Cells were treated with cycloheximide for
indicated time, and Snail1 level was analysed by western blotting. (H) Western blot analysis of wt and S112A mutant Snail1 in the presence/
absence of OGA inhibitors PUGNAc or NAG-Thiazoline. a-tubulin was used as a loading control.
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a determining step in Snail1 metabolism (Dominguez et al,
2003; Yook et al, 2005, 2006). It has been shown that Wnt
signalling and b-catenin activity regulate the Axin2-mediated
nuclear export function of GSK-3b (Yook et al, 2006).
Through Wnt signalling, GSK-3b serially phosphorylates
several Ser/Thr sites on Snail1. The O-phosphorylation of
Ser96, Ser104, and Ser107 is prerequisite to generation of a
recognition site for the ubiquitin-ligase b-TrCP (Yook et al,
2005). In this study, we found that O-GlcNAc modification of
Ser112 stabilized Snail1 by inhibiting its O-phosphorylation.
This in turn resulted in down-regulation of E-cadherin and
initiated the EMT. Hence, the O-GlcNAc modification on
Snail1 has the same functional importance as for the tumour
suppressor p53 (Yang et al, 2006). O-phosphorylation of p53
at Thr155, which causes its ubiquitination and degradation,
is inhibited by O-GlcNAc modification of the adjacent Ser149
(Yang et al, 2006). Although no crystal structure of Snail1 is
currently available, it similarly appears that O-GlcNAc mod-
ification of Ser112 affects casein kinase1’s priming phospho-
rylation of Ser104 and Ser 107, inhibiting GSK-3b-mediated
degradation of Snail1 (Xu et al, 2010).
Transgenic mice overexpressing Snail1 about 20% above
normal frequently develop carcinomas and leukaemia, which
shows the importance of regulated Snail1 expression for
normal organ homeostasis in vivo (Perez-Mancera et al,
2005). On the other hand, persistent hyperglycaemic condi-
tion in diabetic rats has been shown to result in enhanced
OGT expression in various tissues and a general increase
in protein O-GlcNAc modification (Akimoto et al, 2003).
Our present observation of a dynamic interplay between
O-phosphorylation and O-GlcNAc modification of Snail1
and the influence of hyperglycaemia clearly bears a relation
Figure 4 Hyperglycaemic condition increases Snail1 in an OGT-dependent manner. (A) Western blot analysis for endogenous Snail1 and
O-GlcNAc from A549 cells under normoglycaemic (5 mM) and hyperglycaemic (25 mM) conditions. a-tubulin is shown as the loading control.
(B) siRNA-mediated knock-down of OGT and western blot analysis for endogenous Snail1 or OGT from A549 cells under normo- and
hyperglycaemic conditions. a-tubulin was included as a loading control. (C) Western blot analysis of wt or S112A mutant Snail1 from HEK293
cells under normo- and hyperglycaemic conditions. a-tubulin is shown as the loading control. (D) Western blot analysis of wt or S112A mutant
Snail1 in HEK293 cells overexpressing OGT. a-tubulin is shown as the loading control. (E) Western blot analysis for endogenous Snail1 from
MCF-7, HeLa, and SW480 cells under normoglycaemic (5 mM) and hyperglycaemic (25 mM) conditions. a-tubulin is shown as the loading
control. (F) MCF-7, HeLa, and SW480 cells were grown under hyperglycaemic condition (25 mM) and their cell lysates were subjected to
sWGA-lectin-affinity purification and the precipitates analysed with western blot for endogenous Snail1. The inhibitory monosaccharide
GlcNAc (20 mM) was added during sWGA-lectin-affinity purification.
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to both conditions and provides insight into the correlation
between metabolic disease and EMT. It also suggests hyper-
glycaemic conditions as observed in diabetics could be one of
the factors eventually resulting in dysregulation of Snail1
expression and subsequent initiation of the EMT programme.
As OGT is a glucose sensor, its catalytic activity being con-
trolled by substrate UDP-GlcNAc, whose concentrations are
determined by glucose influx (Love and Hanover, 2005; Hart
et al, 2007), our results link the glucose sensing function of
OGT, stabilization of Snail1 through O-GlcNAc modification
by OGT, and long-term consequences of diabetes. Epidemio-
logical studies have provided compelling evidence that meta-
bolic disorders such as obesity and diabetes mellitus are
associated with a higher risk of developing cancer compared
with normoglycaemic individuals, irrespective of other con-
founding factors (Calle and Kaaks, 2004; Coughlin et al, 2004;
Jee et al, 2005; Larsson et al, 2005, 2007; LeRoith et al, 2008).
Although chronic hyperinsulinaemia and serum levels of in-
sulin-like growth factor receptor (IGF-R) have been related to
increased cancer risk and mortality in diabetics (Fernandez
et al, 2001; Calle and Kaaks, 2004), our data indicate that
glucose levels might be another important contributing condi-
tion. As we have shown, hyperglycaemic condition is an
important regulator for Snail1 as the resulting increased
O-GlcNAc modification stabilizes it prior to transcriptional
suppression of E-cadherin and induction of EMT. Interestingly,
activation of IGF-R mediated by NFkB also induces EMT
through transcriptional up-regulation of Snail1 (Kim et al,
2007). Indeed, we have recently shown that NFkB is activated
by O-GlcNAc modification at Thr352, resulting in decreased
binding to IkB (Yang et al, 2008). Together, these results also
suggest that chronic hyperglycaemic condition such as in
diabetes mellitus contributes to the development and progres-
sion of cancer and that Snail1 might be an important part of this
cascade.
What other possible effects could result from hyperglycae-
mia-induced stabilization of Snail1? A main function of Snail1
is to regulate cell movement during embryonic development
(Barrallo-Gimeno and Nieto, 2005). In this context, it has
long been recognized that the risk of congenital malformation
and prenatal mortality is greatly increased by diabetes
mellitus during pregnancy (Nielsen et al, 2005; Kapoor
et al, 2007). The level of O-GlcNAc protein modification
normally fluctuates during early embryogenesis (Dehennaut
et al, 2009), and its dysregulation may lead to developmental
abnormalities, as OGT knock-out in mice is embryonic lethal
(Shafi et al, 2000). This suggests that a maternal hypergly-
caemic condition could be responsible for congenital mal-
formations because of increased O-GlcNAc modification
of important regulatory proteins such as the Snail1, NFkB,
and p53. Other complications of chronic hyperglycaemia are
organ fibrosis and extra deposition of extracellular matrix
components. Aberrant activation of Snail1 has been reported
to disrupt renal tissue homeostasis and to result in fibrosis
(Boutet et al, 2006). Moreover, we have also shown that
OGA inhibition regulates transcription of EMT genes such
as claudin-1, occludin, vimentin, and fibronectin
(Supplementary Figure 6). It would thus be interesting to
analyse the Snail1 O-GlcNAc state under chronic hypergly-
caemia in various tissues affected by fibrosis.
In summary, hyperglycaemia-regulated O-GlcNAc modifi-
cation of Snail1 leads to loss of its E-cadherin suppressor
function. As this may have a key function in diverse pathol-
ogies, further functional studies are required to determine the
effects of O-GlcNAc on Snail1, particularly in the develop-
ment and progression of cancer and other diseases.
Materials and methods
Reagents and DNA transfection
A549, HEK 293, MCF-7, HeLa, and SW480 cells were cultured in
DMEM (Gibco, Grand Island, NY) supplemented with 10% foetal
bovine serum, 100 U/ml penicillin, and 100mg/ml streptomycin at
371C in 5% CO2. A human Snail1 expression vector with a C-terminal
FLAG and HIS epitope tag were described previously (Yook et al, 2005,
Figure 5 O-GlcNAc modification on Snail1 regulates E-cadherin
expression. (A) Left panel: gene reporter assay for wt or 3xMut
E-cadherin promoter in the presence (þ ) or absence () of OGA
inhibitors PUGNAc or NAG-Thiazoline under normoglycaemic
conditions (n¼ 3, data are presented as mean±s.d., *Po0.01 by
Student’s t-test). Right panel: quantitative real-time (RT)–PCR for
E-cadherin mRNA in the presence (þ ) or absence () of OGA
inhibitors PUGNAc or NAG-Thiazoline under normoglycaemic con-
ditions (n¼ 4, data are presented as mean±s.d., *Po0.01 by
Student’s t-test). GAPDH was used for normalization. (B) Left
panel: gene reporter assay for wt or 3xMut E-cadherin promoter
following siRNA knock-down of OGT under hyperglycaemic condi-
tions (n¼ 3, data are presented as mean±s.d., *Po0.01 by Student’s
t-test). Right panel: quantitative RT–PCR for E-cadherin mRNA after
siRNA knock-down of OGT hyperglycaemic conditions (n¼ 3, data
are presented as mean±s.d., **Po0.02 by Student’s t-test). GAPDH
was used for normalization. (C) Left panel: gene reporter assay for wt
or 3xMut E-cadherin promoter under normoglycaemic (5 mM) or
hyperglycaemic (25 mM) conditions (n¼ 3, data are presented as
mean±s.d., *Po0.01 by Student’s t-test). Right panel: quantitative
RT–PCR for E-cadherin mRNA under normo- or hyperglycaemic
conditions (n¼ 4, data are presented as mean±s.d., *Po0.01 by
Student’s t-test). GAPDH was used for normalization.
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2006). Mutants of Snail1 cDNA with FLAG and HIS epitope, including
the D87–109, D110–120, S111A, S112A, S111A, and S112A mutants,
were produced by PCR-based methods using a wild-type Snail1 cDNA
as template, followed by subcloning into the pCR3.1 expression vector.
A human OGT cDNA was subcloned into the pcDNA3.1-HIS-V5
mammalian expression vector (Invitrogen) and the p3xFLAG-CMV-7.1
expression vector (Sigma, St Louis, MO). siRNA of OGT and control
siRNA were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). DNA plasmid and siRNA were transiently transfected into HEK
293 cells using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions.
PUGNAc was purchased from Toronto Research Chemicals Inc.
(ON, Canada) and NTZ was kindly provided by Dr Kwan Soo Kim
(Yonsei University, Seoul, Korea). Cells were treated with 100 mM
PUGNAc or 50mM NTZ for 24 h before cell harvest or for 6 h before
transfection. Cycloheximide and MG132 were purchased from
Sigma. Wild-type or mutant Snail1-FLAG proteins were detected
using anti-FLAG antibody (F-7425 for polyclonal and F-3156 for
monoclonal, Sigma). CTD110.6, an antibody against O-GlcNAc was
purchased from Covance (Princeton, NJ). Antibodies against OGT
(Sigma) and against phosphor-Ser (clone 4A4, Upstate) were
commercially available. Endogenous Snail1 was detected with an
anti-Snail1 monoclonal antibody (Cell Signaling Technology).
Antibodies against a-tubulin and ubiquitin were purchased from
Santa Cruz Biotechnology. Immunoblot analysis and immunopre-
cipitation were performed as described previously (Yook et al, 2005;
Yang et al, 2006).
sWGA-affinity purification
A549 cells were lysed with NET lysis buffer (150 mM NaCl, 50 mM
Tris, pH 7.4, 1 mM EDTA, 0.5% Nonidet P-40) and cell lysates were
incubated with agarose-conjugated sWGA (Vector Laboratories,
Burlingame, CA) for 3 h at 41C. For control of specificity, 20 mM
GlcNAc was added. Precipitates were washed four times with lysis
buffer and proteins were eluted by boiling in SDS sample buffer.
Quantitative real-time PCR
Detection of mRNA transcripts was performed using a 7300 Real-
Time PCR System (Applied Biosystems, Forster City, CA) and SYBR
Green (Takara, Japan). First-strand cDNA was synthesized using
SuperscriptIII (Invitrogen) according to the manufacturer’s instruc-
tions. Primers that amplify human Snail1, E-cadherin, or GAPDH
were designed with Primer3 software (Whitehead Institute
for Biomedical Research). PCR were as follows: Snail1 forward,
50-TGGATACAGCTGCTTTGAGC; Snail1 reverse, 50-GGAGCTTCCCAGT
GAGTCTG; E-cadherin forward, 50- ATGGGGTCTTGCTATGTTGC;
E-cadherin reverse, 50- AAGGCAGAAGGATTGCTTGA; GAPDH for-
ward, 50- CGACCACTTTGTCAAGCTCA; GAPDH reverse, 50- CCCTG
Figure 6 Snail1 O-GlcNAc modification induces cell migration and in vivo invasion. (A) The migratory activity of MCF-7 cells transfected with
flag-tagged OGT-expression vector relative to cells transfected with a control vector (Mock) alone or in combination with shRNA vector control
(vector) or shRNA for Snail1 (shSnail) in tandem was determined after 2 days in culture. OGT induces cell migration, which was
largely attenuated by knock-down of Snail1 (scale bar, 100 mm, n¼ 5, data are presented as mean±s.d., *Po0.01 by Student’s t-test).
(B) Overexpression of OGT in non-invasive MCF-7 cells turns them invasive in chick chorioallantoic membrane (CAM) assay. Combined
expression of OGT and shSnail1 in non-invasive MCF-7 prevents the OGT effect by suppression of Snail1. MCF-7 cells labelled with fluorescent
nanobeads were cultured atop the CAM of live chick embryos for 3 days. Tissues were then removed and unstained frozen sections examined
by fluorescence microscopy to directly visualize the invasive activity of the green-coloured cancer cells (upper panels, scale bar, 100 mm), or
H&E-stained cross-sections prepared for light microscopy (lower panels). The upper face of the chorioallantoic membrane is indicated by the
dashed white lines in the fluorescent images. Arrows denote invasive cancer cells. Immunoblot analysis detects transfected OGT (anti-flag) and
knock-downed endogenous Snail1 in MCF-7 cells to verify the shRNA for Snail1 (right panels).
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TTGCTGTAGCCAAAT. Quantitative real-time PCR (RT–PCR) was
performed in triplicate, and the mRNA levels of Snail1 and
E-cadherin were normalized to GAPDH.
Transwell cell migration assay
For migration assays, MCF-7 cells were transfected with flag-tagged
OGT expression vector (0.5mg) in combination with 1.0mg of
shRNA vector control or shRNA for Snail1 with lipofectamine. After
24 h, cells were trypsinized and 1105 cells seeded into Transwell
inserts (8.0mm pore, BD Biosciences). After an 18 h culture period,
the upper side of the membrane was rubbed with cotton swap and
the numbers of cells migrating to the basal side insert were counted
following 0.25% crystal violet staining. Cell counts were deter-
mined in five random fields from three replicate wells.
Chick CAM invasion assay
The CAM assay for in vivo invasion was performed as described
previously (Yook et al, 2005, 2006). In brief, control-transfected
MCF-7 cells, OGT with shRNA vector-transfected cells, or OGT with
shRNA for Snail1-transfected cells labelled with fluoresbrite
carboxylate nanospheres (Polysciences) were cultured atop the
CAM of 11-day-old chick embryos for 3 days. Invasion was
monitored in haematoxylin–eosin-stained cross-sections of fixed
CAM and by immunofluorescence microscopy.
Tissue samples and immunohistochemistry
Samples of paraffin-embedded primary pancreatic adenocarcino-
mas were obtained from the archive of the Department of
Pathology, Gangnam Severance Hospital, Seoul, Korea. Following
antigen retrieval by microwave heating in citrate buffer (DakoCy-
tomation, Glostrup, Denmark), sections from CAM assay specimens
or pancreactic adenocarcinoma samples were incubated with
antibodies against OGT, Snail1, and keratin, and bound antibody
was visualized with the avidin–biotin-complex peroxidase techni-
que (Dako). Sections were stained with methyl green. In controls,
primary antibodies were omitted.
Mapping of O-GlcNAc site using mass spectrometry
To map O-GlcNAc sites, ESI-MS/MS was performed as previously
described (Yang et al, 2006). Overexpressed wild-type Snail1-FLAG
proteins were purified using FLAG-M2 agarose (Sigma) and
subjected to SDS–PAGE. In-gel digestion with trypsin (Promega,
Madison, WI) (25 ng/ml) and chymotrypsin (Roche) (25 ng/ml) was
simultaneously performed for 16 h at 371C. The peptide analysis
was carried out using a QSTAR Pulsar quadrupole TOF mass
spectrometer (Applied Biosystems) equipped with nanoelectrospray
ion sources (Protana, Odense, Denmark). Database search for
sequenced peptides was performed in the National Center for
Biotechnology Information (Bethesda, MD) non-redundant data-
base using the MASCOT software package (Matrix Sciences,
London, UK).
Reporter gene assays
Reporter constructs for Ecad(-108)-Luc (wt) or Ecad(-108)/Ebox-
A.MUT/EboxB.MUT/EboxC.MUT-Luc (3x Mut) were described
previously (Yook et al, 2005, 2006). A549 cells were transfected
with 1.0mg of reporter gene Ecad(-108)-Luc or Ecad(-108)/Ebox-
A.MUT/EboxB.MUT/EboxC.MUT-Luc. Reporter gene activities were
measured with a dual luciferase assay system (Promega) 48 h after
transfection and normalized by measuring co-transfected control
pRL-SV40 renilla luciferase activity. Reporter gene activities are
presented as light units relative to that obtained from mock-
transfected cells. The results are expressed as averages of ratios of
reporter activities.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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